Texas: FDA approves first plasma therapy for Houston Methodist COVID-19 patient

Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. This treatment was fast-tracked to the bedside over the weekend as the death toll in the COVID-19 pandemic soared to more than 2,000 people across the ["]

The post Texas: FDA approves first plasma therapy for Houston Methodist COVID-19 patient appeared first on Outbreak News Today.